139 related articles for article (PubMed ID: 17848842)
21. Spectroscopic markers of bone quality in alendronate-treated postmenopausal women.
Boskey AL; Spevak L; Weinstein RS
Osteoporos Int; 2009 May; 20(5):793-800. PubMed ID: 18769963
[TBL] [Abstract][Full Text] [Related]
22. [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate].
Buffo L; Rossini M; Buoncristiano A; Girardello S; Zamberlan N; Diani F; Adami S
Minerva Ginecol; 1996 Jun; 48(6):263-72. PubMed ID: 8927288
[TBL] [Abstract][Full Text] [Related]
23. Etidronate and alendronate in the treatment of postmenopausal osteoporosis.
Beauchesne MF; Miller PF
Ann Pharmacother; 1999 May; 33(5):587-99. PubMed ID: 10369624
[TBL] [Abstract][Full Text] [Related]
24. Looking beyond low bone mineral density: multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy.
Lee P; van der Wall H; Seibel MJ
J Endocrinol Invest; 2007; 30(7):590-7. PubMed ID: 17848842
[TBL] [Abstract][Full Text] [Related]
25. Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report.
Iwamoto J; Takeda T
J Orthop Sci; 2002; 7(6):707-12. PubMed ID: 12486478
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-score>-2.5 for alendronate therapy: a modeling study.
Schousboe JT; Ensrud KE; Nyman JA; Kane RL; Melton LJ
J Clin Densitom; 2006; 9(2):133-43. PubMed ID: 16785071
[TBL] [Abstract][Full Text] [Related]
27. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
Tan W; Sun J; Zhou L; Li Y; Wu X
J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
[TBL] [Abstract][Full Text] [Related]
28. [Should bisphosphonate treatment be used for super-old patients with osteoporosis?].
Harada A; Yamamoto S; Kurato S; Iwase T; Inoue K; Sasaki Y; Tanaka T; Fujita M; Nakano T; Ando F
Nihon Ronen Igakkai Zasshi; 2006 Jul; 43(4):459-61. PubMed ID: 16937933
[No Abstract] [Full Text] [Related]
29. Osteoporotic fractures and vitamin D deficiency.
Wong P; Anpalahan M
Aust Fam Physician; 2006 Jul; 35(7):519-20, 522. PubMed ID: 16820826
[TBL] [Abstract][Full Text] [Related]
30. Persistence with weekly alendronate therapy among postmenopausal women.
Lo JC; Pressman AR; Omar MA; Ettinger B
Osteoporos Int; 2006; 17(6):922-8. PubMed ID: 16609824
[TBL] [Abstract][Full Text] [Related]
31. Determinants of adherence to osteoporosis treatment in clinical practice.
Rossini M; Bianchi G; Di Munno O; Giannini S; Minisola S; Sinigaglia L; Adami S;
Osteoporos Int; 2006; 17(6):914-21. PubMed ID: 16538553
[TBL] [Abstract][Full Text] [Related]
32. Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men.
Khosla S; Melton LJ; Achenbach SJ; Oberg AL; Riggs BL
J Clin Endocrinol Metab; 2006 Mar; 91(3):885-91. PubMed ID: 16368747
[TBL] [Abstract][Full Text] [Related]
33. Pelvic insufficiency fracture related to autosomal dominant polycystic kidney disease.
Ubara Y; Higa Y; Tagami T; Suwabe T; Nomura K; Kadoguchi K; Hoshino J; Sawa N; Katori H; Takemoto F; Kitajima I; Hara S; Takaichi K
Am J Kidney Dis; 2005 Dec; 46(6):e103-11. PubMed ID: 16310561
[TBL] [Abstract][Full Text] [Related]
34. New insights into the propagation of fatigue damage in cortical bone using confocal microscopy and chelating fluorochromes.
Zarrinkalam KH; Kuliwaba JS; Martin RB; Wallwork MA; Fazzalari NL
Eur J Morphol; 2005; 42(1-2):81-90. PubMed ID: 16123027
[TBL] [Abstract][Full Text] [Related]
35. Sacral insufficiency fractures following multilevel instrumented spinal fusion: case report.
Khan MH; Smith PN; Kang JD
Spine (Phila Pa 1976); 2005 Aug; 30(16):E484-8. PubMed ID: 16103844
[TBL] [Abstract][Full Text] [Related]
36. Microcracks in cortical bone: how do they affect bone biology?
O'Brien FJ; Brennan O; Kennedy OD; Lee TC
Curr Osteoporos Rep; 2005 Jun; 3(2):39-45. PubMed ID: 16036100
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
